Respiratory Syncytial Virus (RSV) Immunizations
Pronounced (sin-SISH-uhl or RSV)
Print
Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious. Infants and older adults are more likely to develop severe RSV and need hospitalization. Vaccines are available to protect older adults from severe RSV. Vaccines for pregnant people or monoclonal antibody products are available to protect infants and young children from severe RSV.
CDC Recommendations
Adults ages 60 years and older
CDC recommends an RSV vaccine for everyone ages 75 and older and adults ages 60-74 at increased risk of severe RSV.
Adults 60-74 who are at increased risk include those with chronic heart or lung disease, certain other chronic medical conditions, and those who are residents of nursing homes or other long-term care facilities.
RSV vaccine is not currently an annual vaccine, meaning older adults do not need to get a dose every RSV season. That means if you have already gotten an RSV vaccine, you do not need to get another one at this time.
The best time to get vaccinated is in late summer and early fall — just before RSV usually starts to spread in the community.